Home / Search Results

Search Results

You searched for:

The COVID-19 pandemic brought renewed attention to the concept of the home being a site of care. Looking to the future, certain strategies can be implemented for cancer programs aiming to offer care to patients in their homes.
An interview with Kathi Mooney, PhD, RN, FAAN, about the Huntsman at Home model, including the development and implementation of Symptom Care at Home.
ACCC, along with other stakeholders, signed a letter of support for legislation to recognize certified genetic counselors as healthcare providers, giving beneficiaries improved access to these services.
Read about this model that engages oncology stakeholders in advancing biomarker testing and application into practice, increasing access to state-of-the-art genomic testing and clinical trials.
Learn how Vanderbilt-Ingram Cancer Center in Nashville, Tenn. has been using monitoring devices for patients undergoing chimeric antigen receptor (CAR) T-cell therapy. Thanks to this technology, these high-risk patients can be remotely monitored 24/7.
Advanced Practice Providers able to sign anti-cancer therapy orders practice at the top of their license and can help free up physician time to see more new patients, streamline clinic workflows, and improve the patient experience.
A deep dive into 4 topics discussed during a series of interactive sessions at the ACCC 49th Annual Meeting and Cancer Center Business Summit: business and artificial intelligence technology, research and clinical trials, and precision medicine.